The idea of using fibrinolytic agents in the treatment of coronary thrombosis is attractive and obvious. The onset of the disease is acute and clearly defined, the disease itself is a very serious one, present methods of treatment leave so much to be desired, and even if one were unable to save cardiac muscle from necrosis, 4ie lesser goal of restoring to And what were our results ? Briefly, wholly negative. Of the treated group, nine patients died, of the untreated eight. From the 14 necropsies the hearts were all examined by the one pathologist who was not told beforehand from which group they came. He did not find fewer thrombi in the main arteries; he did not find fewer thrombi in the small vessels though he did find the capillaries more dilated in the treated series. This is the opposite to what he should have found. Nor did he find less inflammation around the infarct. In our analyses of the electrocardiograms we found slightly less ST elevation (a mere I mm.) at 24 hours in the treated group but no difference otherwise. In our analyses of the transaminase curves we found no significant differences whatever. 
The idea of using fibrinolytic agents in the treatment of coronary thrombosis is attractive and obvious. The onset of the disease is acute and clearly defined, the disease itself is a very serious one, present methods of treatment leave so much to be desired, and even if one were unable to save cardiac muscle from necrosis, 4ie lesser goal of restoring to the patient a patent coronary artery is well worth pursuing. For all these reasons 
